> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
> See specialized channels

  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter

Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library

| Print |
Thursday, 24 April 2008 15:59 (UTC + 2)



Munich, Germany, April 24, 2008 / b3c newswire / ->Sloning BioTechnology and Roger Kornberg’s group at Stanford University are working on a project to synthesize a gene mutant library where selected codons are introduced in a statistically expected and controlled ratio at preselected positions within a given DNA sequence.
Sloning will utilize its core technology, Slonomics™, a unique DNA engineering platform using defined sets of double stranded DNA triplets to generate this highly sophisticated kind of gene mutant library.
The group of Dr. Roger Kornberg (Nobel Prize Laureate in Chemistry 2006) at Stanford University will perform in vivo screens based on the library provided by Sloning to identify relevant mutants of a S. cerevisiae RNA Polymerase II.

Jan Van den Brulle, Scientific Director at Sloning commented, “We are looking forward to work together with Dr. Kornberg’s group. This project gives us again the opportunity to demonstrate the power of our technology”.Dr. Kornberg stated, "this mutant library will allow us to dissect and better understand the transcription mechanism."

About Sloning -
Located in Munich, Germany, Sloning is a private company with the number one technology for the synthesis of diverse genetic libraries. Diverse genetic libraries are essential in the screening for new and improved therapeutic proteins or proteins used in technical applications. Sloning uses Slonomics™ to synthesize customised mutant libraries for its customers from the biopharmaceutical, industrial biotech, agribiotech and food industries worldwide. In particular, Sloning takes an ethical approach to synthetic biology and is a founder member of the Industry Association of Synthetic Biology formulating industry standards for biosafety and biosecurity.

Dr. Jan Van den Brulle, Scientific Director 49 89 80 95 – 0
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it